| Title |
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
|
|---|---|
| Published in |
Cancer Immunology, Immunotherapy, July 2013
|
| DOI | 10.1007/s00262-013-1453-3 |
| Pubmed ID | |
| Authors |
Einar Osland Vik-Mo, Marta Nyakas, Birthe Viftrup Mikkelsen, Morten Carstens Moe, Paulina Due-Tønnesen, Else Marit Inderberg Suso, Stein Sæbøe-Larssen, Cecilie Sandberg, Jan E. Brinchmann, Eirik Helseth, Anne-Marie Rasmussen, Knut Lote, Steinar Aamdal, Gustav Gaudernack, Gunnar Kvalheim, Iver A. Langmoen |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 25% |
| Unknown | 6 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 88% |
| Scientists | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 187 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 1 | <1% |
| United States | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 184 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 30 | 16% |
| Student > Bachelor | 30 | 16% |
| Researcher | 25 | 13% |
| Student > Master | 21 | 11% |
| Student > Doctoral Student | 13 | 7% |
| Other | 29 | 16% |
| Unknown | 39 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 50 | 27% |
| Agricultural and Biological Sciences | 28 | 15% |
| Biochemistry, Genetics and Molecular Biology | 19 | 10% |
| Immunology and Microbiology | 11 | 6% |
| Neuroscience | 11 | 6% |
| Other | 20 | 11% |
| Unknown | 48 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 November 2023.
All research outputs
#2,328,363
of 26,017,215 outputs
Outputs from Cancer Immunology, Immunotherapy
#96
of 3,029 outputs
Outputs of similar age
#19,210
of 210,551 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#2
of 19 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,029 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,551 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.